Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings by Feasey, NA et al.
1 
 
Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income 1 
settings and invasive disease in low-income settings  2 
 3 
 4 
Authors 5 
Nicholas A. Feasey 1,2,3,4, James Hadfield 2, Karen H. Keddy 5, Tim Dallman 21, Jan 6 
Jacobs 6,7, Xiangyu Deng 8,9, Paul Wigley 4, Lars Barquist 10, Gemma C. Langridge 7 
2, Theresa Feltwell 2, Simon R. Harris 2, Alison E. Mather 2*, Maria Fookes 2, Martin 8 
Aslett 2, Chisomo Msefula 3,11, Samuel Kariuki 12, Calman Maclennan 2,13, Robert 9 
S. Onsare 12, François X. Weill 14, Simon Le Hello 14, Anthony M. Smith 5, Michael 10 
McClelland 15, Prereak Desai 15, Christopher M. Parry 16,17, John Cheesbrough 18, 11 
Neil French 4, Josefina Campos 19, Jose A. Chabalgoity 20, Laura Betancor 20, Katie 12 
L. Hopkins 21, Tom J. Humphrey 22, Octavie Lunguya 23,24, Tristan A. Cogan 25, 13 
Milagritos Tapia 26, Samba Sow 27, Sharon M. Tennant 26, Kristin Bornstein 26, 14 
Myron M. Levine 26, Lizeth Lacharme-Lora 4, Dean B. Everett 4, Robert A. Kingsley 15 
2,28, Julian Parkhill 2, Robert S. Heyderman 3,29, Gordon Dougan 2, Melita A 16 
Gordon† 3,4 & Nicholas R. Thomson† 2, 30 17 
 18 
†These authors contributed equally 19 
 20 
Affiliations 21 
1. Liverpool School of Tropical Medicine, Liverpool, UK 22 
2. Wellcome Trust Sanger Institute, Cambridge, UK 23 
3. Malawi Liverpool Wellcome Trust Clinical Research Programme, University of Malawi College of 24 
Medicine, Blantyre, Malawi 25 
4. Institute of Infection and Global Health, University of Liverpool, Liverpool, UK 26 
5. National Institute for Communicable Diseases and Faculty of Health Sciences, University of the 27 
Witwatersrand, Johannesburg, South Africa 28 
6. Institute of Tropical Medicine, Antwerp, Belgium 29 
7. Department of Microbiology and Immunology, University of Leuven, Belgium 30 
8. Center for Disease Control, Atlanta, USA 31 
9. Center for Food Safety, Department of Food Science and Technology, University of Georgia 32 
10. Institute for Molecular Infection Biology, University of Würzburg, Würzburg, Germany 33 
2 
 
11. University of Malawi, The College of Medicine, Blantyre, Malawi 34 
12. Centre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya 35 
13. Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK 36 
14. Institut Pasteur, Paris, France 37 
15. Department of Microbiology and Molecular Genetics, University of California, Irvine, CA, USA 38 
16. London School of Hygiene & Tropical Medicine, London, UK 39 
17. School of Tropical Medicine and Global Health, Nagasaki University, Japan 40 
18. Department of Epidemiology and Population Health, University of Liverpool, Liverpool, UK 41 
19. Enteropathogen Division, Administración Nacional de Laboratorios e Institutos de Salud (ANLIS) 42 
Carlos G. Malbran Institute, Buenos Aires, Argentina 43 
20. Departamento Desarrollo Biotecnologico, Instituto de Higiene, Facultad de Medicina, Universidad de la 44 
Republica, Uruguay 45 
21. Public Health England, Colindale, UK 46 
22. Swansea Medical School, Swansea University, Swansea, UK 47 
23. National Institute of Biomedical Research, Kinshasa, the Democratic Republic of the Congo 48 
24. University Hospital of Kinshasa, Kinshasa, the Democratic Republic of the Congo 49 
25. School of Veterinary Sciences, University of Bristol, Bristol, UK 50 
26. Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA 51 
27. Centre pour le Développement des Vaccins, Bamako, Mali 52 
28. Institute of Food Research, Colney, Norwich, UK 53 
29. Division of Infection and Immunity, University College London, London, UK 54 
30. The London School of Hygiene and Tropical Medicine, London, UK 55 
* Current address: Department of Veterinary Medicine, University of Cambridge, Cambridge, UK 56 
 57 
 58 
Corresponding Author 59 
Nicholas Feasey 60 
Liverpool School of Tropical Medicine 61 
5 Pembroke Place 62 
Liverpool  63 
L3 5QA 64 
Tel: 0151 705 3214 65 
 66 
Running Title: Emergence of distinct lineages of S. Enteritidis  67 
Key words: Salmonella Enteritidis, global, multidrug resistant, bacteraemia, 68 
gastroenteritis  69 
  70 
3 
 
Abstract 71 
An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In 72 
high-income settings, it has been responsible for an epidemic of poultry-associated, 73 
self-limiting enterocolitis, whilst in sub-Saharan Africa it is a major cause of invasive 74 
nontyphoidal Salmonella disease, associated with high case-fatality. Whole-genome 75 
sequence analysis of 675 isolates of S. Enteritidis from 45 countries reveals the 76 
existence of a global epidemic clade and two novel clades of S. Enteritidis that are 77 
each geographically restricted to distinct regions of Africa. The African isolates 78 
display genomic degradation, a novel prophage repertoire and have an expanded, 79 
multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella 80 
serotype that displays niche plasticity, with distinct clades that enable it to become a 81 
prominent cause of gastroenteritis in association with the industrial production of 82 
eggs, and of multidrug resistant, bloodstream invasive infection in Africa.  83 
  84 
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Introduction 85 
 86 
Salmonella enterica serovar Enteritidis (hereafter referred to as S. Enteritidis) has 87 
been a global cause of major epidemics of enterocolitis, which have been strongly 88 
associated with intensive poultry farming and egg production [1]. The serovar is 89 
usually considered to be a generalist in terms of host range and has a low human 90 
invasiveness index, typically causing self-limiting enterocolitis [2]. Following a 91 
number of interventions in the farming industry involving both improved hygiene 92 
and poultry vaccination, epidemic S. Enteritidis has been in decline in many 93 
countries including the United Kingdom and USA [3,4]. S. Enteritidis has also been 94 
used extensively since the early 1900s as a rodenticide (named the “Danysz virus”), 95 
following development at Institut Pasteur, France. Although by the 1960s, 96 
Salmonella-based rodenticides had been banned in the US, Germany and the UK, S. 97 
Enteritidis is still produced as a rodenticide in Cuba, under the name Biorat®[5]. 98 
 99 
Serovars of Salmonella that cause enterocolitis in industrialised settings are strongly 100 
associated with life-threatening invasive nontyphoidal Salmonella (iNTS) disease in 101 
sub-Saharan Africa (SSA). S. Enteritidis and Salmonella enterica serovar 102 
Typhimurium (S. Typhimurium) are the two leading causes of iNTS disease in SSA 103 
[6] and both are associated with multidrug resistance (MDR)[7]. The clinical 104 
syndrome iNTS disease is associated with immunosuppression in the human host, 105 
particularly malnutrition, severe malaria and advanced HIV in young children and 106 
advanced HIV in adults [8]. It has been estimated to cause 681,000 deaths per year 107 
[9].  108 
 109 
Salmonella is a key example of a bacterial genus in which there is a recognizable 110 
genomic signature that distinguishes between a gastrointestinal and an extra-111 
intestinal/invasive lifestyle [10], whereby functions required for escalating growth 112 
in an inflamed gut are lost when the lineage becomes invasive [11]. In order to 113 
investigate whether there were distinct bacterial characteristics explaining the very 114 
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different epidemiological and clinical profile of epidemic isolates of serotype S. 115 
Typhimurium from SSA and industrialised settings, whole-genome sequence (WGS) 116 
investigations of this serovar were previously undertaken. These revealed a novel 117 
pathotype of multilocus sequence type (MLST) ST313 from SSA, which differed from 118 
clades that cause enterocolitis in industrialised settings, by showing patterns of 119 
genomic degradation potentially associated with more invasive disease and 120 
differential host adaptation [12-17]. 121 
 122 
In relation to S. Enteritidis, there is a growing body of literature on the evolutionary 123 
history, phylogeny and utility of WGS for surveillance of S. Enteritidis outbreaks [18-124 
20]. The broadest study of the phylogeny to date revealed five major lineages, but 125 
contained only two African isolates [21]. There have also been limited reports of 126 
isolates of S. Enteritidis from African patients living in Europe that are MDR and 127 
which display a distinct phage type (PT 42) [22,23]. We therefore hypothesized that 128 
there are distinct lineages of S. Enteritidis circulating in both the industrialised and 129 
developing world with different origins, likely distinct routes of spread and that are 130 
associated with different patterns of disease, which will display the distinct genomic 131 
signatures characteristic of differential adaptation. To investigate this we have 132 
collected a highly diverse global collection of S. Enteritidis isolates and compared 133 
them using whole-genome sequencing, the highest possible resolution typing 134 
methodology. 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
  143 
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Results 144 
 145 
Isolate collection 146 
 147 
In total, 675 isolates of S. Enteritidis isolated between 1948 and 2013 were 148 
sequenced. The collection originated from 45 countries and six continents (Table 1). 149 
496/675 isolates were from Africa, with 131 from the Republic of South Africa 150 
(RSA), a further 353 from the rest of SSA, and 12 from North Africa (Table 1). There 151 
were 343 isolates from normally sterile human sites (invasive), 124 non-invasive 152 
human isolates (predominantly stool samples) and 40 from animal, food or 153 
environmental sources. The full metadata are described in Supplementary Table 1 154 
and have been uploaded to the publically available database Enterobase  155 
(https://enterobase.warwick.ac.uk/). 156 
Phylogeny  157 
 158 
675 S. Enteritidis genomes and one Salmonella enterica serovar Gallinarum were 159 
mapped to the S. Enteritidis strain P125109 reference sequence, variable regions 160 
excluded and the remaining sites were screened for single nucleotide 161 
polymorphisms (SNPs). This left an alignment file containing a total of 42,373 162 
variable sites, from which a maximum likelihood (ML)-phylogeny was constructed 163 
using S. Gallinarum, which is a closely related serovar, as an out-group (Figure 1). 164 
HierBAPS was run over two rounds, which provided clear distinction between 165 
clades/clusters [24]. The phylogeny of S. Enteritidis revealed evidence of three 166 
clades associated with epidemics, one which we have termed the ‘global epidemic 167 
clade’ and includes the reference PT4 isolate P125109 and two African clades: one 168 
predominantly composed of West African isolates (labeled the ‘West African clade’) 169 
and a second composed of isolates predominantly originating in Central and Eastern 170 
Africa, called the ‘Central/Eastern African clade’). Figure 1 also shows the other 171 
clades and clusters predicted by HierBAPS, the largest of which is a paraphyletic 172 
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cluster from which the global epidemic clade emerged (Outlier Cluster in Figure 1), 173 
and a further five smaller clades or clusters predicted by HierBAPS. 174 
 175 
The global epidemic clade contains isolates of multiple phage types, including 4 and 176 
1, which have been linked to the global epidemic of poultry associated human 177 
enterocolitis [25]. It comprised 250 isolates from 28 countries, including 43 from 178 
Malawi and 82 from RSA. They were isolated from across a 63-year period (1948-179 
2013). Antimicrobial susceptibility testing had been performed on 144 isolates and 180 
104 were susceptible to all antimicrobials tested, five were multidrug resistant 181 
(MDR: resistant to 3 or more antimicrobial classes), one was nalidixic acid resistant 182 
and none were extended-spectrum beta-lactamase (ESBL)-producing isolates. 183 
Database comparison of the genomes from this clade revealed that 221 (88%) of 184 
them contained no predicted antimicrobial resistance (AMR) genes apart from the 185 
cryptic resistance gene aac(6')-Iy [26]. 186 
 187 
The global epidemic clade has emerged from a diverse cluster previously described 188 
by Zheng [27], which encompassed 131 isolates (Figure 1: ‘Outlier Cluster’). In 189 
addition to being paraphyletic, this group was geographically and temporally 190 
diverse, and predominantly drug susceptible (59/71 isolates). Whilst the majority of 191 
the diversity of phage typed isolates was contained within the global epidemic clade, 192 
this cluster alone contained isolates of phage type 14b, which was recently 193 
associated with a multi-country outbreak of S. Enteritidis enterocolitis in Europe 194 
associated with chicken eggs from Germany [28]. There were also 41 isolates from 195 
RSA in this clade, where it has been a common cause of bloodstream infection, and 196 
39 bloodstream isolates from Malawi. Database comparison of the genomes from 197 
this clade revealed that 122 (82%) of these genomes contained no predicted AMR 198 
genes apart from the cryptic resistance gene aac(6')-Iy. 199 
 200 
There were two related, but phylogenetically and geographically distinct, epidemic 201 
clades that largely originated from SSA. The Central/Eastern African clade included 202 
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166 isolates, all but two of which (from RSA) came from this region. Of these, 203 
126/155 (82%) were MDR and 148/153 (97%) displayed phenotypic resistance to 204 
between one and four antimicrobial classes. All of these genomes contained at least 205 
five predicted resistance genes and 128 (77%) contained nine (Table 2 and 206 
Supplementary Table 2). 155/165 (94%) of these isolates were cultured from a 207 
normally sterile compartment of a human (i.e. blood or cerebrospinal fluid) and 208 
were considered to be causing invasive disease (Table 2). The second African 209 
epidemic clade was significantly associated with West Africa with 65/66 isolates 210 
coming from this region and one isolate from USA. This clade was also associated 211 
with drug resistance (62 [94%] resistant to ≥1 antimicrobial class by phenotype and 212 
genotype) and human invasive disease (61 [92%]). It also included two isolates that 213 
were subtyped as phage type 4. 214 
 215 
The remaining 58 isolates included in this study were extremely diverse, 216 
phylogenetically, temporally and geographically. Only two displayed any phenotypic 217 
AMR, one of which was MDR. Inspection of the genome revealed that five had 218 
predicted AMR genes in addition to aac(6')-Iy, four of which were isolated in sub-219 
Saharan Africa. Twenty were associated with invasive human disease, and six were 220 
recovered from stool. Three isolates were from stocks of rodenticide and these were 221 
phylogenetically remote from both global-epidemic and the two African epidemic 222 
clades.  223 
 224 
To add further context to these findings we screened the entire publically available 225 
Public Health England (PHE) sequenced Salmonella collection, which includes 2,367 226 
S. Enteritidis genomes, 41 of which were associated with travel to Africa 227 
(Supplementary Figure 1). Within this huge collection, only 6 isolates (4 from blood 228 
culture, 1 from stool) fell within to the West African clade and 1 (from stool) 229 
belonged to the Central/Eastern African clade. Notably, these isolates were all 230 
associated with either travel to Africa and/or taken from patients of African origin.  231 
 232 
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 233 
It is apparent from the location of the archetypal reference isolate and archetypal 234 
phage types in the phylogeny (Supplementary Figure 2) that the majority of S. 235 
Enteritidis studied previously belonged to the global epidemic clade associated with 236 
enterocolitis in industrialised countries. What is more its also clear that two 237 
additional, previously unrecognized S. Enteritidis lineages have emerged, largely 238 
restricted to Africa, that are strongly associated with MDR and invasive disease.  239 
 240 
To understand how recently these African-associated lineages emerged we used 241 
Bayesian Evolutionary Analysis by Sampling Trees (BEAST) to reconstruct the 242 
temporal history of the epidemic clades [29]. These data (Supplementary Figure 3) 243 
estimate the most recent common ancestor (MRCA) of the Central/Eastern African 244 
clade dates to 1945 (95% Credible Interval [CrI]: 1924-1951) and for the West 245 
African clade it was 1933 (95% CrI: 1901-1956). We estimate the MRCA of the 246 
global epidemic clade originated around 1918 (95% CrI: 1879-1942 – 247 
Supplementary Figure 4), with a modern expansion occurring in 1976 (95% CrI: 248 
1968-1983), whereas the paraphyletic cluster from which it emerged dates to 249 
approximately 1711 (95% CrI: 1420-1868). 250 
 251 
The contribution of the accessory genome to the emergence of the African 252 
clades 253 
 254 
Prophages have the potential to carry non-essential "cargo" genes, which suggests 255 
they confer a level of specialization to their host bacterial species, whilst plasmids 256 
may confer a diverse array of virulence factors and AMR [30,31]. Therefore it is 257 
critical to evaluate the accessory genome in parallel with the core. 622 sequenced 258 
genomes were used to determine a pangenome, which yielded a core genome 259 
comprising 4,076 predicted genes present in ≥90% isolates, including all 12 260 
recognised Salmonella Pathogenicity Islands as well as all 13 fimbrial operons found 261 
in the P125109 reference [32]. The core gene definition was set to minimize 262 
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stochastic loss of genes from the core due to errors in individual assemblies across 263 
such a large dataset. The accessory genome consisted of 14,015 predicted genes. Of 264 
the accessory genes, 324 were highly conserved across the global and two African 265 
epidemic clades, as well as the outlier cluster. Almost all were associated with the 266 
acquisition or loss of mobile genetic elements (MGEs) such as prophage or plasmids. 267 
Prophage regions have been shown to be stable in Salmonella genomes and are 268 
potential molecular markers, the presence of which has previously been used to 269 
distinguish specific clades [13,33]. 270 
 271 
The lineage-specific whole gene differences of the major clades are summarized in 272 
Figure 2 and plotted against the representatives of the four major clades in 273 
Supplementary Figure 3. The lineage specific sequence regions include 57 predicted 274 
genes found to be unique to the global epidemic clade (Figure 2), all of which were 275 
associated with prophage ϕSE20, a region shown to be essential for invasion of 276 
chicken ova and mice in one previous study [34]. There were a further 39 genes 277 
conserved in the global epidemic and the paraphyletic outlying cluster, which were 278 
absent from both African clades, 26 of which correspond to region of difference 279 
(ROD) 21 [32]. The Central/Eastern Africa clade contained 77 predicted genes that 280 
were absent in the other clades. 33 were associated with the virulence plasmid and 281 
a further 40 chromosomal genes were associated with a novel, Fels-2 like prophage 282 
region (fels-BT). The West African clade had only 15 distinct predicted genes, 11 of 283 
which were plasmid-associated. The two African clades shared a further 102 genes: 284 
48, including a leucine-rich repeat region, were associated with a novel prophage 285 
region closely related to Enterobacter phage P88, 44 were associated with a Gifsy-1 286 
prophage found in S. Bovismorbificans and eight were associated with a Gifsy-2 287 
prophage which has degenerated in the reference P125109.  288 
 289 
The S. Enteritidis plasmid is the smallest of the generic Salmonella virulence 290 
plasmids at 58 kb and is unusual in that it contains an incomplete set of tra genes 291 
that are responsible for conjugative gene transfer. The phylogeny of the S. 292 
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Enteritidis virulence plasmid backbone was reconstructed using reads that mapped 293 
to the S. Enteritidis reference virulence plasmid, pSENV. 120/675 (18%) genomes 294 
lacked pSENV. The virulence plasmid phylogeny is similar to that of the 295 
chromosome, suggesting that they have been stably maintained by each lineage and 296 
diversified with them (Supplementary Figure 6).  297 
 298 
The virulence plasmids from the African clades were much larger than those held in 299 
the other clades at ~90 kb. A representative example was extracted from Malawian 300 
isolate D7795, sequenced using long read technology to accurately reconstruct it 301 
(PacBio; see methods) and denoted pSEN-BT (Accession number LN879484). pSEN-302 
BT is composed of a backbone of pSENV with additional regions that are highly 303 
similar to recently sequenced fragments of an novel S. Enteritidis virulence plasmid 304 
(pUO-SeVR) isolated from an African patient presenting with MDR invasive S. 305 
Enteritidis in Spain [22, 23]. Plasmid pSEN-BT harbours nine AMR genes (full list in 306 
Supplementary Table 2), plus additional genes associated with virulence and a 307 
toxin/antitoxin plasmid addiction system. Of note, plasmids from the West African 308 
isolates carry resistance gene chloramphenicol acetyl transferase A1 (catA1), 309 
whereas the Central/Eastern African strains carry catA2 and tetracycline resistance 310 
gene tet(A). Like pSENV, the African virulence plasmid contained an incomplete set 311 
of tra genes and so is not self-transmissible. This was confirmed by conjugation 312 
experiments and is consistent with previous reports [22,23]. These observations 313 
suggest that the evolution of the S. Enteritidis plasmid mirrors that of the 314 
chromosome; it is thus not a ‘novel’ plasmid, but in different SSA locations has 315 
acquired different AMR genes. 316 
 317 
Multiple signatures of differential host adaptation 318 
 319 
It has been observed in multiple serovars of Salmonella including S. Typhi, S. 320 
Gallinarum and S. Typhimurium ST313 that the degradation of genes necessary for 321 
the utilization of inflammation-derived nutrients is a marker of that lineage having 322 
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moved from an intestinal to a more invasive lifestyle [13,14,32,35]. Accordingly, we 323 
have looked for similar evidence within a representative example of a MDR, 324 
invasive, Central/Eastern African clade isolate, D7795, that was isolated from the 325 
blood of a Malawian child in 2000. The draft genome sequence of D7795 closely 326 
resembles that of P125109, however, in addition to the novel prophage repertoire 327 
and plasmid genes described above, it harbours a number of predicted pseudogenes 328 
or hypothetically disrupted genes (HDGs)[11].  329 
 330 
In total, there were 42 putative HDGs in D7795, many of which are found in genes 331 
involved in gut colonisation and fecal shedding as well as various metabolic 332 
processes such as cobalamine biosynthesis which is a cofactor for anaerobic 333 
catabolism of inflammation-derived nutrients, such as ethanolamine, following 334 
infection [36]. Curation of the SNPs and insertions or deletions (indels) predicted to 335 
be responsible for pseudogenisation across the Central/Eastern African clade and 336 
West African clade revealed 37/42 predicted HDGs were fixed in other 337 
representatives of the Central/East African clade, with 27 of them being present in 338 
over 90% of isolates from that clade. Relatively fewer HDGs in D7795 (19/42) were 339 
present in representatives of the West African clade, although 13 were present in 340 
≥90% of isolates (Supplementary Table 3).   341 
 342 
In addition to this evidence of reductive evolution in D7795, there were 363 genes 343 
containing non-synonymous (NS)-SNPs, which change the amino acid sequence and 344 
so may have functional consequences [37]. The two African clades were screened 345 
for the presence of these NS-SNPs and 131 were found to be present and completely 346 
conserved across both clades, including NS-SNPs in 43 genes encoding predicted 347 
membrane proteins, 36 metabolic genes and 23 conserved hypothetical genes 348 
(Supplementary Table 4). Furthermore many of these NS-SNPs fall in genes within 349 
the same metabolic pathways as the HDGs (see Supplementary Results for detailed 350 
description).  Supplementary Table 5 provides a list of some of the common traits 351 
identified amongst the functions of genes lost independently by D7795, S. Typhi and 352 
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S. Gallinarum. The disproportionate clustering of mutations in membrane structures 353 
observed in the African clades is yet another sign of differential host adaptation 354 
analogous to that reported in both S. Typhi [35] and S. Gallinarum [32].  355 
 356 
BiologTM growth substrate platform profiling 357 
 358 
The BiologTM platform was utilized to generate a substrate growth utilisation profile 359 
for selected S. Enteritidis isolates (see high throughput phenotyping protocol in 360 
Supplementary materials). Corresponding signal values of replicate pairs of a 361 
Central/Eastern African isolate (D7795) and a global epidemic isolate (A1636) were 362 
compared using principal component analysis and found to be highly consistent. In 363 
total, 80 metabolites showed evidence of differential metabolic activity (Figure 3). 364 
Evaluation of data from the Central/Eastern African isolate using Pathway Tools 365 
software revealed that 14/27 (52%) of pathways with evidence of decreased 366 
metabolic activity at 28˚C had a corresponding component of genomic degradation. 367 
This was also true for 12/30 (40%) of pathways with evidence of decreased 368 
metabolic activity at 37oC.  369 
 370 
Instances of reduced metabolic activity in a Central/Eastern African strain (D7795) 371 
compared to a global epidemic strain (A1636) included dulcitol and glycolic acid in 372 
the glycerol degradation pathway, propionic acid in the propanediol pathway and 373 
ethylamine and ethanolamine. These are all vitamin B12 (cobalamin) dependent 374 
reactions, for which there was a corresponding signature of genomic degradation. 375 
Also there was reduced activity in response to three forms of butyric acid, alloxan 376 
and allantoic acid metabolism. Allantoin can be found in the serum of birds, but not 377 
humans and is utilised as a carbon source during S. Enteritidis infection of chickens, 378 
[38] and HDGs relating to allantoin have been noted in S. Typhimurium ST313 [13]. 379 
The full list of differences is detailed in Supplementary Table 6 and 7. This is a 380 
further sign of decreased metabolism of the Central/Eastern African isolate in the 381 
anaerobic environment of the gut.  382 
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 383 
Chicken infection model suggests evolutionary divide in host range between 384 
global epidemic and African lineages 385 
 386 
Given the phenotypic differences observed in the genotypically distinct global and 387 
African clades, we hypothesized that these lineages could have differing infection 388 
phenotypes in an in vivo challenge model. We compared the infection profile of a 389 
member of the Central/Eastern African clade (D7795) to the reference global 390 
epidemic strain P125109 in an avian host. The chicken group infected with P125109 391 
showed mild hepatosplenomegaly consistent with infection by this Salmonella 392 
serovar and cecal colonization (Figure 4A-C). In contrast, the Central/Eastern 393 
African strain displayed significantly reduced invasion at 7 dpi of both liver 394 
(p=0.027) and spleen (p=0.007), however cecal colonization was not significantly 395 
reduced (p=0.160). This is in marked contrast to the behavior of S. Typhimurium 396 
ST313, which is more invasive in a chick infection model [12].  397 
 398 
 399 
Discussion 400 
 401 
S. Enteritidis is an example of a successful Salmonella lineage with the apparent 402 
ability to adapt to different hosts and transmission niches as and when 403 
opportunities for specialization have presented. Langridge et al recently evaluated 404 
the Enteritidis/Gallinarum/Dublin lineage of Salmonella, revealing components of 405 
the nature and order of events associated with host-range and restriction [39]. In 406 
the present study, we have highlighted the plasticity of S. Enteritidis, providing 407 
evidence of three distinct epidemics of human disease. In addition we show multiple 408 
additional clades and clusters that demonstrate the huge reservoir of diversity 409 
amongst S. Enteritidis from which future epidemics might emerge.  410 
 411 
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An important question posed by this study is why have distinct clades of Salmonella 412 
emerged to become prominent causes of iNTS disease in Africa, from a serotype 413 
normally considered to be weakly invasive? The presence of a highly 414 
immunosuppressed population due to the HIV pandemic is clearly a key host factor 415 
that facilitates the clinical syndrome iNTS disease [40,41]. In addition to human host 416 
factors, there are two distinct African epidemic lineages that have emerged in the 417 
last 90 years. Both lineages are significantly associated with a novel prophage 418 
repertoire, an expanded, MDR-augmented virulence plasmid, and patterns of 419 
genomic degradation with similarity to other host-restricted invasive Salmonella 420 
serotypes including S. Typhi and S. Gallinarum and to clades of S. Typhimurium 421 
associated with invasive disease in Africa [13,32,35]. This pattern of genomic 422 
degradation is concentrated in pathways specifically associated with an enteric 423 
lifestyle, however it is noteworthy that in the chick infection model, the African S. 424 
Enteritidis invaded the chick liver and spleen less well than the global pandemic 425 
clade. This raises the possibility that the two clades occupy different ecological 426 
niches outside the human host or that they behave differently within the human 427 
host and screening of the huge S. Enteritidis collection from the UK PHE supports 428 
the assertion that these lineages are geographically restricted to Africa. This study 429 
therefore indicates a need to understand what these ecological niches might be, and 430 
then to define the transmission pathways of African clades of S. Enteritidis, in order 431 
to facilitate public health interventions to prevent iNTS disease. 432 
 433 
The evolution of the S. Enteritidis virulence plasmid is intriguing; pSENV is the 434 
smallest of the known Salmonella virulence-associated plasmids, but in SSA, the 435 
plasmid has nearly doubled in size partly through the acquisition of AMR genes. The 436 
absence of tra genes necessary for conjugal transfer either indicates that MDR status 437 
has evolved through acquisition of MGEs multiple times or through clonal expansion 438 
and vertical transmission of the plasmid to progeny. The available data suggest that 439 
the former scenario has happened twice, once in West Africa, and once in 440 
Central/Eastern Africa.  441 
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 442 
Despite S. Enteritidis being reported as a common cause of bloodstream infection 443 
(BSI) in Africa [6,7] the Global Enteric Multicenter Study (GEMS) found that 444 
Salmonella serotypes were an uncommon cause of moderate to severe diarrhoea in 445 
African children less than 5-years of age [42]. Our data associating the African 446 
epidemic lineages with invasive disease is also consistent with data presented in a 447 
recent independent Kenyan study comparing a limited number and diversity of S. 448 
Enteritidis isolates from blood and stool. Using the lineages defined in this study on 449 
the genome data reported from Kenya showed that 20.4% of isolates belonging to 450 
the global clade were associated with invasive disease, whereas 63.2% of the 451 
isolates in that study fall within our Central/Eastern African clade [43], the 452 
remainder being associated with stool carriage, or enterocolitis. This association of 453 
S. Enteritidis clades circulating in sub-Saharan Africa with iNTS disease may reflect 454 
that their geographical distribution permits them to act as opportunistic invasive 455 
pathogens in a setting where advanced immunosuppressive disease is highly 456 
prevalent in human populations.  457 
 458 
In summary, two clades of S. Enteritidis have emerged in Africa, which have 459 
different phenotypes and genotypes to the strains of S. Enteritidis circulating in the 460 
industrial world. These strains display evidence of changing host adaptation, 461 
different virulence determinants and multi-drug resistance, a parallel situation to 462 
the evolutionary history of S. Typhimurium ST313. They may have different 463 
ecologies and/or host ranges to global strains and have caused epidemics of BSI in 464 
at least three countries in SSA, yet are rarely responsible for disease in South Africa. 465 
An investigation into the environmental reservoirs and transmission of these 466 
pathogens is warranted and urgently required. 467 
 468 
Methods 469 
 470 
Bacterial Isolates 471 
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 472 
S. Enteritidis isolates were selected on the basis of six factors; date of original 473 
isolation, antimicrobial susceptibility pattern, geographic site of original isolation, 474 
source (human [invasive vs stool], animal or environmental), phage type (where 475 
available), and multilocus variable number tandem repeat (MLVA) type (where 476 
available). S. Enteritidis P125109 (EMBL accession no. AM933172) isolated from a 477 
poultry farm from the UK was used as a reference [32]. The full metadata are in 478 
Supplementary Table 1. Isolates have been attributed to region according to United 479 
Nations statistical divisions 480 
(http://unstats.un.org/unsd/methods/m49/m49regin.htm). 481 
 482 
Sequencing, SNP-calling, construction of phylogeny and comparative genomics 483 
 484 
PCR libraries were prepared from 500 ng of DNA as previously described [44]. 485 
Isolates were sequenced using Illumina GA II, HiSeq 2000 and MiSeq machines 486 
(Illumina, San Diego, CA, USA) and 150 bp paired-end reads were generated.  The 487 
strains were aligned to Salmonella Enteritidis reference genome P125109 using a 488 
pipeline developed in-house at the Wellcome Trust Sanger Institute (WTSI). For 489 
each isolate sequenced, the raw sequence read pairs were split to reduce the overall 490 
memory usage and allow reads to be aligned using more than one CPU. The reads 491 
were then aligned using SMALT (www.sanger.ac.uk/science/tools/smalt-0), a 492 
hashing based sequence aligner. The aligned and unmapped reads were combined 493 
into a single BAM file. Picard (https://broadinstitute.github.io/picard) was used to 494 
identify and flag optical duplicates generated during the making of a standard 495 
Illumina library, which reduces possible effects of PCR bias. All of the alignments 496 
were created in a standardized manner, with the commands and parameters stored 497 
in the header of each BAM file, allowing for the results to be easily reproduced.  498 
 499 
The combined BAM file for each isolate was used as input data in the SAMtools 500 
mpileup program to call SNPs and small indels, producing a BCF file describing all of 501 
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the variant base positions [45]. A pseudo-genome was constructed by substituting 502 
the base call at each variant or non-variant site, defined in the BCF file, in the 503 
reference genome. Only base calls with a depth of coverage >4 or quality >50 were 504 
considered in this analysis. Base calls in the BCF file failing this quality control filter 505 
were replaced with the "N” character in the pseudo-genome sequence.  506 
  507 
All of the software developed is freely available for download from GitHub under an 508 
open source license, GNU GPL 3.  509 
 510 
Phylogenetic modelling was based on the assumption of a single common ancestor, 511 
therefore variable regions where horizontal genetic transfer occurs were excluded 512 
[46] [47]. A maximum likelihood (ML) phylogenetic tree was then built from the 513 
alignments of the isolates using RAxML (version 7.0.4) using a GTR+I+G model [48]. 514 
The maximum-likelihood phylogeny was supported by 100 bootstrap pseudo-515 
replicate analyses of the alignment data. Clades were predicted using Hierarchical 516 
Bayesian Analysis of Population Structure (HierBAPS)[24]. This process was 517 
repeated to construct the plasmid phylogeny, using reads that aligned to pSENV.  518 
The phylogeny of the  Public Health England collection is defined on the basis of a 519 
SNP-address scheme. Seventeen isolates representing the diversity of the collection 520 
analyzed in this study were placed in the context of 168 genomes representing each 521 
50-SNP cluster present in the PHE collection by constructing a ML-tree. 522 
 523 
Temporal reconstruction was performed using Bayesian Evolutionary Analysis 524 
Sampling Trees (BEAST: http://beast.bio.ed.ac.uk/ version 1.8.2)[49]. A relaxed 525 
lognormal clock model was initially employed. The results of this model indicated 526 
that a constant clock model was not appropriate, as the posterior of the standard 527 
deviation of the clock rate did not include zero. A range of biologically plausible 528 
population models (constant, exponential and skyline) was investigated. Skyline 529 
models can be biased by non-uniform sampling and we observed a strong similarity 530 
between reconstructed skyline population and the histogram of sampling dates and 531 
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so this model was excluded. The exponential models consistently failed to converge 532 
and were excluded. Thus, for all datasets, lognormal clock and constant population 533 
size models were used. The computational expense required for this analysis 534 
precluded running estimators for model selection. However, we note that Deng et al 535 
used the same models in their analysis of 125 S. Enteritidis isolates. Default priors 536 
were used except for ucld.mean, Gamma(0.001,1000), initial: 0.0001; 537 
exponential.popSize, LogNormal(10,1.5), initial: 1[21].  538 
 539 
Three chains of 100 million states were run in parallel for each clade of the four 540 
major HierBAPS clades, as well as a fourth chain without genomic data to examine 541 
the influence of the prior, which in all cases was uninformative. The final results, as 542 
used here, all had effective sample sizes (ESS) of over 200 and had convergence 543 
between all three runs. For the Global and Global Outlier lineages, the datasets were 544 
not computationally feasible to analyse. We thus created 3 further random subsets 545 
of the data by drawing n isolates from each sampled year where n was sampled 546 
from a Poisson distribution where λ=2. The posteriors of all subsets were extremely 547 
similar and runs were combined to produce the final most recent common ancestor 548 
(MRCA) estimates. 549 
 550 
In order to gain a detailed insight into genomic differences, a single high quality 551 
sequence from Malawian S. Enteritidis isolate D7795 was aligned against the 552 
P125109 using ABACAS and annotated [50]. Differences were manually curated 553 
against the reference using the Artemis Comparison Tool (ACT)[51]. Sections of 554 
contigs which were incorporated into the alignment, but which did not align with 555 
P125109 were manually inspected and compared to the public databases using 556 
BLASTn (http://blast.ncbi.nlm.nih.gov). When these regions appeared to be novel 557 
prophages, they were annotated using the phage search tool PHAST and manually 558 
curated [52]. In order to investigate whether the SNPs and/or indels that were 559 
predicted to be responsible for pseudogene formation in D7795 were distinct to that 560 
isolate or conserved across both African epidemic clades, all isolates were aligned to 561 
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P12509 and the relevant SNPs/indels investigated using in-silico PCR of the aligned 562 
sequences. Manual curation was performed to confirm the nature of all pseudogene 563 
associated SNPs/indels. NS-SNPs identified in D7795 were sorted throughout the 564 
African clades by extracting and aligning the appropriate gene sequences from 565 
P125109 and D7795. The coordinates of the NS-SNPs were then used to identify the 566 
relevant sequence and determine the nature of the base.  567 
 568 
Accessory genome 569 
The pangenome for the dataset was predicted using ROARY [53]. Genes were 570 
considered to be core to S. Enteritidis if present in ≥90% of isolates. A relaxed 571 
definition of core genome was used as assemblies were used to generate it and the 572 
more assemblies one uses, the more likely it is that a core gene will be missed in one 573 
sample due to an assembly error. The remaining genes were considered to be core 574 
to the clades/clusters predicted by HierBAPS if present in ≥75% if isolates from 575 
within each clade/cluster. These genes were then curated manually using ACT to 576 
search for their presence and position in P125109 or the improved draft assembly 577 
of representative isolates of each of the other clades if not present in P125109. Any 578 
large accessory regions identified were blasted against the assembled genomes of 579 
the entire collection to confirm they were grossly intact. 580 
 581 
Plasmid identification  582 
Plasmid DNA was extracted from isolate D7795 using the Kado & Liu method and 583 
separated by gel-electrophoresis alongside plasmids of known size, to estimate the 584 
number and size of plasmids present [54]. Plasmid conjugation was attempted by 585 
mixing 100 μL of overnight culture of donor and recipient strains (rifampicin 586 
resistant Escherichia coli C600) on Luria-Bertani agar plates and incubating 587 
overnight at 26°C and 37°C. The plasmid was sequenced using the PacBio platform 588 
(http://www.pacificbiosciences.com/) to gain long reads and a single improved 589 
draft assembly, which was aligned against P125109 plasmid pSENV (Accession 590 
Number HG970000). For novel regions of the plasmid from isolate D7795, genes 591 
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were predicted using GLIMMER and manual annotations applied based on 592 
homology searches against the public databases, using both BLASTn and FASTA. The 593 
plasmid phylogeny was reconstructed using the same methodology as the 594 
chromosome; a maximum likelihood (ML) phylogenetic tree was built from the 595 
alignments of the isolates using RAxML (version 7.0.4) using a GTR+I+G model 596 
 597 
Identification of AMR genes 598 
 599 
A manually curated version of the Resfinder database was used to investigate the 600 
isolates for the presence of AMR genes [55]. To reduce redundancy, the database 601 
was clustered using CD-HIT-EST [56], with the alignment length of the shorter 602 
sequence required to be 90% the length of the longer sequence. All other options 603 
were left as the defaults. The representative gene of each cluster was then mapped 604 
with SMALT (http://www.sanger.ac.uk/science/tools/smalt-0) to the assemblies of 605 
each isolate to identify and matches with an identity of 90% or greater were 606 
considered significant, in line with the default clustering parameters of CD-HIT-EST. 607 
Where partial matches were identified at the ends of contigs, having an identity of 608 
90% or greater to the matched region of the gene, potential AMR gene presence was 609 
recorded. To confirm presence of these partial matches, raw sequencing reads of the 610 
pertinent isolates were mapped using SMALT to these genes to check for 90% 611 
identity across the entire gene. 612 
 613 
 614 
BiologTM growth substrate platform profiling 615 
 616 
The BiologTM platform (http://www.biolog.com) enables the simultaneous 617 
quantitative measurement of a number of cellular phenotypes, and therefore the 618 
creation of a phenotypic profile of a variety of assay conditions [57]. Incubation and 619 
recording of phenotypic data were performed using an OmniLog® plate reader. In 620 
these experiments, two replicates of D7795 were compared to two of PT4-like strain 621 
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A1636 at 28 and 37˚C to represent environmental and human temperatures. 622 
BiologTM plates PM1-4 and 9 (Carbon source [PM1, PM2], nitrogen source [PM3] and 623 
phosphor and sulphur source [PM4] metabolism and osmotic pressure [PM9]) were 624 
used. Each well was inoculated as described in the high throughput phenotyping 625 
protocol, thereby testing 475 conditions at once (each plate has one negative control 626 
well). Plates were scanned every 15 min for 48 hours while incubated at 28°C and 627 
37°C in air. Two paired replicates were performed for each of the two isolates. 628 
 629 
After completion of the run, the signal data were compiled and analysed using the 630 
limma package (www.bioconductor.org) in ‘R’ (www.R-project.org) as described 631 
previously [58]. A log-fold change of 0.5 controlling for a 5% false discovery rate 632 
was used as a cut-off for investigating a specific metabolite further using Pathway 633 
Tools [59] and whether the metabolic change was related to pseudogenes and non 634 
synonymous(NS)-SNPs in genes in the respective genomes. 635 
 636 
In vivo Infection Model 637 
 638 
Two isolates were used in the animal models: S. Enteritidis P125109 and D7795. 639 
Unvaccinated commercial female egg-layer Lohmann Brown chicks (Domestic Fowl 640 
[Gallus gallus]) were obtained from a commercial hatchery and housed in secure 641 
floor pens at a temperature of 25°C. Eight chicks per strain per time point were 642 
inoculated by gavage at 10 days (d) of age and received a dose of ~108 Salmonella 643 
colony forming units (CFU) in a volume of 0.2 mL. Subsequently, four to five birds 644 
from each group were humanely killed at 3, 7 or 21 d post-infection (p.i.). At post 645 
mortem, the liver, spleen, and caecal contents were removed aseptically, 646 
homogenised, serially diluted and dispensed onto Brilliant Green agar (Oxoid) to 647 
quantify colony forming units (CFU) as described previously [60]. Statistical analysis 648 
was performed using SPSS, version 20 (IBM). Kruskal-Wallis was used to compare 649 
bacterial loads between infected groups. 650 
 651 
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All work was conducted in accordance with the UK legislation governing 652 
experimental animals, Animals (Scientific Procedures) Act 1986, under project 653 
licence 40/3652 and was approved by the University of Liverpool ethical review 654 
process prior to the award of the project license.   The licensing procedure requires 655 
power calculations to determine minimal group sizes for each procedure to ensure 656 
results are significant. For these experiments a group size of 8 birds per time point 657 
was chosen, based on a variation in 1.0 log10 in bacterial count between groups as 658 
being significant along with prior experience of Salmonella infection studies. Groups 659 
were randomly selected on receipt from the hatchery and investigators conducting 660 
animal experiments were not blinded, as the current UK code of practice requires all 661 
cages or pens to be fully labeled with experimental details. No animals were 662 
excluded from the analysis.  All animals were checked a minimum of twice daily to 663 
ensure their health and welfare. 664 
 665 
Code availability 666 
 667 
Software is referenced and URLS are provided in the text of the methods, all 668 
software is open source.  669 
  670 
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Tables 884 
Table 1: Summary of metadata (n) by region in numbers  885 
 886 
 887 
*Multidrug resistant: resistant to ≥3 antimicrobials 888 
†Extended spectrum beta lactamase producing 889 
‡Uruguay strains previously characterised by Betancor [61] 890 
  891 
Region Total Site of isolation Antimicrobial resistance 
phenotype 
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Asia 11 5 5 1 0 0 0 0 0 
Europe 61 0 16 24 2 0 0 0 0 
South America 27‡ 3 6 7 8 0 0 0 0 
North Africa 12 9 1 1 9 0 0 2 0 
Sub-Saharan 
Africa 
353 269 22 7 99 64 14
9 
0 3 
Republic of South 
Africa 
131 57 74 0 83 44 4 0 0 
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Table 2: Metadata summarised by clade 892 
 Major 
Clade/cluster 
Site of isolation 
N (%) 
Number (%) of 
antimicrobial 
resistance genes* 
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1
-3
 
4
-6
 
7
-9
 
West African 61 (92) 1 (2) 0 (0) 4 (6) 22 (33) 9 
(14) 
35 (66) 
Central/Eastern 
African 
155 
(93) 
7 (4) 0 (0) 5 (3) 0 (0) 11 
(7) 
156 
(93) 
Global epidemic 94 (38) 95 
(38) 
31 (12) 30 
(12) 
243 
(97) 
7 (3) 0 (0) 
Outlier cluster 51 (38) 36 
(27) 
27 (20) 20 
(15) 
128 
(96) 
3 (2) 3 (2) 
 893 
*All isolates contained cryptic aminoglycoside acetyltransferase gene aac(6’)-ly[26] 894 
  895 
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 896 
Figures  897 
 898 
Figure 1: Maximum likelihood phylogeny of S. Enteritidis based on 675 isolates 899 
rooted to S. Gallinarum. There are 3 epidemic clades; 2 African epidemic clades and 900 
a global epidemic clade. Scale bar indicates nucleotide substitutions per site.  901 
 902 
Figure 2: Differences in accessory genomes of 4 major clades. Approximate position 903 
of prophages in chromosome is depicted, although prophages are not drawn to scale 904 
 905 
Figure 3: Heat map revealing changes in metabolic activity of Central/Eastern 906 
African clade isolate D7795 when compared to global epidemic isolate A1636 at 28 907 
and 37˚C. The figure also displays whether there are corresponding mutations in 908 
genes related to the affected metabolic pathway. (NSSNP=Non-synonymous single 909 
nucleotide polymorphism, HDG = Hypothetically disrupted gene) 910 
 911 
Figure 4: Salmonella isolation from a chick infection model demonstrates failure of 912 
Central/Eastern African clade isolate to invade chicken spleen (4A) and liver (4B) or 913 
to colonize chicken caeca (4C) at 7 days post infection (dpi) (n=24 at this time point) 914 
compared to the global epidemic clade. Numbers are expressed as colony forming 915 
units (CFU) per gram of tissue 916 
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Supplementary Data 918 
 919 
Supplementary Table 1: Metadata associated with each individual strain including 920 
date, place, and source of isolation plus antimicrobial susceptibility data where 921 
known.  Predicted antimicrobial resistance genes are also included 922 
Supplementary Table 2: Full list of predicted antimicrobial resistance genes 923 
Supplementary Table 3: List of pseudogenes identified in D7795 and confirmation of 924 
presence/absence across African clades  925 
Supplementary Table 4: List of genes in both Central/Eastern and West African 926 
clades with non-synonymous SNPs present throughout both clades  927 
Supplementary Table 5: Comparison of genomic degradation seen in African 928 
epidemic clade with that seen in S. Typhi and S. Gallinarum 929 
Supplementary Table 6: Full list of phenotypic differences between an example of 930 
the Central/Eastern African clade (D7795) and an example of the global epidemic 931 
clade (A1636) at 37˚C and corresponding genetic differences 932 
 Supplementary Table 7: Full list of phenotypic differences between an example of 933 
the Central/Eastern African clade (D7795) and an example of the global epidemic 934 
clade (A1636) at 28˚C and corresponding genetic differences 935 
 936 
Supplementary Figure 1: Maximum likelihood phylogeny placing representative 937 
isolates from current study within the context of the diversity of S. Enteritidis 938 
genomes in the PHE collection.  939 
Supplementary Figure 2: Maximum likelihood phylogeny with strains of known 940 
phage type highlighted, demonstrating the lack of genomic diversity captured by 941 
phage typing  942 
Supplementary Figure 3: BEAST tree of Central/Eastern African Clade and West 943 
African Clades revealing estimated age of clades 944 
Supplementary Figure 4: Histograms of dates and BEAST results (treeHeight) for the 945 
subsets of the outlier cluster (S3A and S3C) and global epidemic clade (S3B and 946 
S3D)  947 
35 
 
Supplementary Figure 5: Distribution of prophage regions across the isolate 948 
collection highlighted. Red indicates presence, blue absence. Gaps indicate isolates 949 
not sequenced at Sanger Institute 950 
Supplementary Figure 6: Maximum likelihood phylogeny of S. Enteritidis plasmids  951 
 952 
High throughput phenotyping protocol 953 
 954 
Supplementary results 955 
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